Compare United Airlines Holdings Inc (UAL) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
United Airlines Holdings Inc vs GeneDx Holdings Corp — how do they compare? United Airlines Holdings Inc trades at $125.25 (market cap $41.00B), while GeneDx Holdings Corp trades at $82.71 (market cap $2.44B). The key difference: United Airlines Holdings Inc is far larger — about 16.8× GeneDx Holdings Corp's market cap, and United Airlines Holdings Inc is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| UAL | WGS | |
|---|---|---|
Market Cap | $41.00B | $2.44B |
Sector | Industrials | Technology |
52-Week High | $136.11 | $167.51 |
52-Week Low | $85.21 | $34.51 |
Enterprise Value | $58.03B | $2.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
United Airlines (UAL) trades at $125.37, up 1.3% today, with a bullish technical signal from moving averages. The stock shows strong fundamentals with a low P/E of 11.83 and robust ROE of 23.25%. Recent earnings have consistently beaten estimates, and revenue is projected to grow to $62.9B in 2026. Analyst sentiment is overwhelmingly positive with a $167.73 consensus price target and no sell ratings.
The outlook for UAL is favorable due to solid earnings momentum and improving debt metrics, though risks include fuel cost volatility and execution of fleet innovation. The stock presents a value opportunity with upside potential, supported by strong institutional buy-in and manageable liabilities.
GeneDx Holdings Corp (WGS) trades at $82.39, up 5.79% in the past 24 hours, with a bullish technical signal and strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating guidance, and returned to adjusted profitability earlier than expected. However, net income remains negative at -$106 million for 2026, and the stock faces class action lawsuits with an August 3, 2026 deadline.
Outlook is mixed: bullish technicals and analyst consensus suggest upside to the $90 price target, but fundamental weaknesses and legal risks pose significant challenges. Investment opportunity hinges on sustained revenue growth and margin improvement, while risks include profitability pressures and litigation outcomes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
